A tablet composition for a controlled and pH-independent release of the pharmaceutically active compound pramipexole from the tablet matrix after oral administration has been provided. The composition comprises a water-soluble, preferably dihydrochloride, salt of pramipexole, at least one non-ionic, not gelling release-controlling polymer and at least one non-ionic, gelling release-controlling polymer.
展开▼
